Zooming out, Chubb\u2019s roughly 15% year to date share price return and five year total shareholder return of about 123% signal momentum that has steadily strengthened as investors reward its resilient underwriting and improving profitability.<\/p>\n
If Chubb\u2019s steady compounding appeals to you, this could be a good moment to broaden your watchlist and explore fast growing stocks with high insider ownership<\/a>.<\/p>\n Yet with shares hovering near analyst targets despite a modest revenue dip but rising profits, the key debate now is clear: is Chubb still trading below its true worth or already pricing in years of future growth?<\/p>\n With Chubb last closing at $313.32 against a narrative fair value near $311, the story hinges less on today\u2019s price and more on tomorrow\u2019s earnings power.<\/p>\n Capital deployment through ongoing share repurchases (new $5B authorization), growing dividends, and selective M&A is creating upward pressure on earnings per share (EPS), while robust cash flow and capital position provide flexibility for further shareholder returns.<\/p>\n Read the complete narrative.<\/a><\/p>\n Curious how modest revenue shrinkage can still support richer margins and a higher future multiple than today. Want to see which assumptions make that math work.<\/p>\n Result: Fair Value of $311.09 (OVERVALUED)<\/p>\n Have a read of the narrative in full and understand what’s behind the forecasts.<\/a><\/p>\n However, softening property pricing and elevated catastrophe losses could quickly erode margins and challenge the assumption that earnings power will steadily grind higher.<\/p>\n Find out about the key risks to this Chubb narrative.<\/a><\/p>\n While the narrative fair value pegs Chubb as about 1% overvalued, its 12.7x earnings multiple looks cheaper than both the US insurance industry at 13.4x and its own 13.8x fair ratio, which hints at potential upside if sentiment keeps improving. Which signal do you trust more?<\/p>\n See what the numbers say about this price \u2014 find out in our valuation breakdown.<\/a><\/p>\n If you see the numbers differently or want to stress test your own assumptions using our tools, you can craft a personalized view in minutes: Do it your way<\/a>.<\/p>\n A great starting point for your Chubb research is our analysis highlighting 2 key rewards and 1 important warning sign<\/a> that could impact your investment decision.<\/p>\n Before you move on, you can use our powerful Screener to uncover fresh opportunities you might otherwise miss across markets, sectors, and themes.<\/p>\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.<\/p>\n Companies discussed in this article include CB<\/a>.<\/p>\n Have feedback on this article? Concerned about the content? Get in touch<\/a> with us directly. Alternatively, email editorial-team@simplywallst.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Chubb (CB) has quietly outperformed the broader insurance space over the past month, climbing about 6% and extending…\n","protected":false},"author":2,"featured_media":21614,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[131],"tags":[240,1104,1779,1271],"class_list":{"0":"post-30165","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-chubb","8":"tag-chubb","9":"tag-fair-value","10":"tag-shareholder-value","11":"tag-total-shareholder-return"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116212405713287861","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/30165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=30165"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/30165\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/21614"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=30165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=30165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=30165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"NYSE:CB](\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/03\/9df4e418d48491eac8a0edd50be01ab1.png\")
<\/a> NYSE:CB PE Ratio as at Dec 2025 <\/p>\n